Strategic Partnering

Merrion goal is to bring to market a significant number of medicines that benefit from our GIPET® and GIRES™ patented technologies. To achieve this, Merrion is working with a series of pharmaceutical partners as well as developing its own products.

We have confidence in our technologies, built from an extensive database of successful studies. We are therefore happy to let partners evaluate these technologies in a rapid and cost-effective feasibility model so that they can also see the potential that GIPET® and GIRES™ can deliver.

To turn the potential of our technologies into new marketed products, Merrion brings a lot to the table:

Strong, experienced and energetic team, focused on end results, and working in an entrepreneurial environment.
Proven scientific expertise in Merrion's technology area.
Broad intellectual property portfolio.
State of the art development facilities, allowing rapid product development.
Ability to manufacture clinical trial materials in cGMP compliant facility.
Extensive database of clinical trials and other supporting data.

If you are considering strategic partnering with Merrion, or are interested in one or more of our current product opportunities, please complete and submit the form below. (Required fields are marked with a *)

*	Name
	Title
*	Company
*	Phone
*	Email
	Comments